Melox

Meloxicam, the active ingredient in Melox, is a nonsteroidal anti-inflammatory drug presented as an injectable solution for intramuscular use. It provides analgesic and anti‑inflammatory effects for conditions such as osteoarthritis, rheumatoid arthritis and other musculoskeletal pain in adults.

GNH USA supplies Melox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is used to manage pain and inflammation associated with musculoskeletal disorders.

Osteoarthritis: reduces joint pain and improves functional ability. Rheumatoid arthritis: alleviates inflammatory joint symptoms and swelling. Acute musculoskeletal pain: provides rapid analgesia and decreases inflammation.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection site reactions: pain, erythema, or swelling.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Gastrointestinal ulceration or bleeding. - Renal impairment: decreased urine output or elevated creatinine.

Precautions should be taken when prescribing meloxicam to ensure patient safety. - Renal function: assess baseline renal status and monitor periodically. - Hepatic function: evaluate liver enzymes before and during therapy. - Cardiovascular risk: use the lowest effective dose in patients with heart disease. - Concomitant NSAIDs: avoid combining with other NSAIDs to reduce gastrointestinal toxicity. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at ambient temperature: keep in original container, protect from moisture and light.

Meloxicam may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: elevated lithium levels and potential toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: risk of renal impairment and electrolyte imbalance. - Methotrexate: decreased clearance leading to toxicity.